We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$485M
AUM Growth
+$32.9M
Cap. Flow
+$7.9B
Cap. Flow %
1,627.32%
Top 10 Hldgs %
29.7%
Holding
511
New
21
Increased
215
Reduced
111
Closed
140
Avg Time Held
9.7 quarters
Top 10 Avg Time Held
10.2 quarters
Top 20 Avg Time Held
9.5 quarters

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$7.87B
2
GD icon
General Dynamics
GD
+$18.3M
3
GSK icon
GSK
GSK
+$15.4M
4
CLX icon
Clorox
CLX
+$3.3M
5
MA icon
Mastercard
MA
+$1.51M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$950K
2
ORCL icon
Oracle
ORCL
+$859K
3
FISV icon
Fiserv Inc
FISV
+$824K
4
HON icon
Honeywell
HON
+$781K
5
CELG
Celgene Corp
CELG
+$779K

Sector Composition

Rank Sector Weight
1 Technology 18.71%
2 Consumer Staples 13.04%
3 Financials 12.7%
4 Healthcare 12.3%
5 Communication Services 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NOC icon
51
Northrop Grumman
NOC
$68.3B
$2.24M 0.46%
5,909
-1,417
-19% -$498K
2016 Q2
14 quarters
BAC icon
52
Bank of America
BAC
$380B
$2.21M 0.46%
64,634
+973
+2% +$31.4K
2014 Q4
20 quarters
TMO icon
53
Thermo Fisher Scientific
TMO
$243B
$2.19M 0.45%
6,484
-723
-10% -$219K
2016 Q2
14 quarters
LMT icon
54
Lockheed Martin
LMT
$118B
$2.17M 0.45%
5,083
-631
-11% -$242K
2015 Q3
17 quarters
BMY icon
55
Bristol-Myers Squibb
BMY
$121B
$2.14M 0.44%
31,821
+9,684
+44% +$555K
2015 Q3
17 quarters
CSCO icon
56
Cisco
CSCO
$467B
$2.14M 0.44%
43,883
+2,993
+7% +$139K
2014 Q4
20 quarters
SO icon
57
Southern Company
SO
$99.1B
$2.07M 0.43%
30,359
+424
+1% +$26.3K
2015 Q4
16 quarters
AMGN icon
58
Amgen
AMGN
$224B
$1.85M 0.38%
7,772
+2,796
+56% +$616K
2015 Q4
16 quarters
MDLZ icon
59
Mondelez International
MDLZ
$77.1B
$1.81M 0.37%
32,636
+3,720
+13% +$199K
2015 Q2
18 quarters
ITW icon
60
Illinois Tool Works
ITW
$75.2B
$1.8M 0.37%
10,112
+352
+4% +$59.6K
2014 Q4
20 quarters
RTX icon
61
RTX Corp
RTX
$251B
$1.77M 0.37%
18,261
+1,303
+8% +$118K
2015 Q4
16 quarters
BABA icon
62
Alibaba
BABA
$277B
$1.71M 0.35%
7,689
-374
-5% -$70.2K
2015 Q4
16 quarters
ADBE icon
63
Adobe
ADBE
$94.3B
$1.69M 0.35%
4,835
-73
-1% -$21.5K
2017 Q1
11 quarters
GD icon
64
General Dynamics
GD
$89.6B
$1.67M 0.34%
110,805
+101,879
+1,141% +$18.3M
2015 Q3
17 quarters
WFC icon
65
Wells Fargo
WFC
$253B
$1.63M 0.34%
33,437
+3,493
+12% +$183K
2015 Q1
19 quarters
SHW icon
66
Sherwin-Williams
SHW
$77.5B
$1.6M 0.33%
8,082
-150
-2% -$28.6K
2015 Q4
16 quarters
NFLX icon
67
Netflix
NFLX
$293B
$1.51M 0.31%
44,530
+4,370
+11% +$130K
2015 Q3
17 quarters
QCOM icon
68
Qualcomm
QCOM
$187B
$1.47M 0.3%
15,556
-7,954
-34% -$665K
2016 Q1
15 quarters
TGT icon
69
Target
TGT
$69.8B
$1.4M 0.29%
12,289
+5,707
+87% +$670K
2015 Q3
17 quarters
CVS icon
70
CVS Health
CVS
$110B
$1.36M 0.28%
18,232
+475
+3% +$33.4K
2015 Q3
17 quarters
ALL icon
71
Allstate
ALL
$58B
$1.35M 0.28%
11,478
+89
+0.8% +$9.71K
2016 Q3
13 quarters
LOW icon
72
Lowe's Companies
LOW
$104B
$1.34M 0.28%
11,079
+1,196
+12% +$137K
2015 Q3
17 quarters
LLY icon
73
Eli Lilly
LLY
$1.05T
$1.3M 0.27%
9,212
+645
+8% +$74.8K
2015 Q1
19 quarters
MRSH icon
74
Marsh
MRSH
$83.9B
$1.28M 0.26%
11,228
+126
+1% +$13.2K
2015 Q3
17 quarters
EW icon
75
Edwards Lifesciences
EW
$49.1B
$1.28M 0.26%
15,816
-309
-2% -$24.1K
2017 Q1
11 quarters

Similar funds

HighPoint Advisor Group's Q4 2019 Portfolio in Review

As of Q4 2019, HighPoint Advisor Group held 511 positions worth $485M, up 7.3% from $452M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

HighPoint Advisor Group deployed $7.9B of net new capital in Q4 2019, opening 21 new positions and adding to 215 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 3,195 shares worth $747K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Oracle, an estimated $859K trimmed.

  • HighPoint Advisor Group's largest Q4 2019 buy was Vertex Pharmaceuticals: 3,195 shares worth $747K.
  • HighPoint Advisor Group added most to Berkshire Hathaway Class A in Q4 2019, an estimated $7.87B increase.
  • HighPoint Advisor Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $859K.
  • HighPoint Advisor Group fully exited American International in Q4 2019, selling an estimated $950K.
  • HighPoint Advisor Group's ten largest holdings make up 30% of its $485M portfolio in Q4 2019.
  • HighPoint Advisor Group opened 21 new positions and closed 140 in Q4 2019.
  • HighPoint Advisor Group's portfolio value rose 7.3% quarter-over-quarter to $485M.

Based on HighPoint Advisor Group's 13F filing for Q4 2019, filed 13 Feb 2020.